| 1 |
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
W REDFERN, Leif G. Carlsson, Alice E. Davis et al. · Cardiovascular Research
|
Apr 2003 |
1,548 |
| 2 |
Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
Teresa Coelho et al. · New England Journal of Medicine
Open access |
28 Aug 2013 |
981 |
| 3 |
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
Kevin J. Fitzgerald, Suellen White, Anna Borodovsky et al. · New England Journal of Medicine
Open access |
13 Nov 2016 |
773 |
| 4 |
Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens
David Kirkland, Marilyn J. Aardema, Leigh M. Henderson et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
|
24 Jun 2005 |
758 |
| 5 |
Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks
Philippa D. Darbre, Philip W. Harvey · Journal of Applied Toxicology
Open access |
16 May 2008 |
704 |
| 6 |
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial
Kevin J. Fitzgerald, Maria D. Frank-Kamenetsky, Svetlana Shulga‐Morskaya et al. · The Lancet
Open access |
3 Oct 2013 |
580 |
| 7 |
The safety of chitosan as a pharmaceutical excipient
Paul Baldrick · Regulatory Toxicology and Pharmacology
|
28 Sep 2009 |
560 |
| 8 |
Reliable Comet assay measurements for detecting DNA damage induced by ionising radiation and chemicals
T. S. Kumaravel, Awadhesh N. Jha · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
|
19 Apr 2006 |
523 |
| 9 |
Fourth International Workgroup on Genotoxicity testing: Results of the in vivo Comet assay workgroup
Brian Burlinson, Raymond R. Tice, Günter Speit et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
|
28 Nov 2006 |
511 |
| 10 |
How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop
David Kirkland et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
|
14 Jan 2007 |
443 |
| 11 |
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
Gregory G. Schwartz et al. · American Heart Journal
Open access |
6 Aug 2014 |
415 |
| 12 |
Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2
Wendy Painter, Wayne Holman, Jim A. Bush et al. · Antimicrobial Agents and Chemotherapy
Open access |
3 Mar 2021 |
401 |
| 13 |
Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries
Mathieu F. Janssen, Ágota Szende, J. Cabases et al. · The European Journal of Health Economics
Open access |
14 Feb 2018 |
354 |
| 14 |
Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging—A Systematic Review and Meta-Analysis
Irıs D. Nagtegaal, Nikki Knijn, Niek Hugen et al. · Journal of Clinical Oncology
ReviewOpen access |
23 Feb 2017 |
320 |
| 15 |
Proton transfer and hydrogen bonding in the organic solid state: a combined XRD/XPS/ssNMR study of 17 organic acid–base complexes
Joanna S. Stevens, Stephen J. Byard, Colin C. Seaton et al. · Physical Chemistry Chemical Physics
Open access |
5 Nov 2013 |
287 |
| 16 |
Population Norms for the EQ-5D
Bas Janssen, Ágota Szende
Book chapterOpen access |
26 Sep 2013 |
259 |
| 17 |
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
Andreas Goette, José Luís Merino, Michael D. Ezekowitz et al. · The Lancet
|
6 Sep 2016 |
249 |
| 18 |
Semaglutide improves postprandial glucose and lipid metabolism, and delays first‐hour gastric emptying in subjects with obesity
Julie Hjerpsted, Anne Flint, Ashley M. Brooks et al. · Diabetes Obesity and Metabolism
Open access |
23 Sep 2017 |
241 |
| 19 |
A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins
David Kirkland, Lesley Reeve, David G. Gatehouse et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
|
15 Jan 2011 |
239 |
| 20 |
Reduction of misleading (“false”) positive results in mammalian cell genotoxicity assays. I. Choice of cell type
Paul Fowler, Katie Smith, Jamie K. Young et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
|
2 Dec 2011 |
226 |
| 21 |
Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA Conjugate
Tracy S. Zimmermann, Verena Karsten, Amy Chan et al. · Molecular Therapy
Open access |
2017 |
217 |
| 22 |
An evaluation framework for new approach methodologies (NAMs) for human health safety assessment
Stanley T. Parish, Michael Aschner, Warren Casey et al. · Regulatory Toxicology and Pharmacology
Open access |
Feb 2020 |
208 |
| 23 |
Self-Reported Population Health: An International Perspective Based on EQ-5D
Ágota Szende, M.B. Janssen, J.M. Cabasés et al. · Value in Health
Open access |
22 Oct 2013 |
197 |
| 24 |
Animal models of mechanisms of SARS‐CoV‐2 infection and COVID‐19 pathology
Simon J. Cleary, Simon C. Pitchford, Richard T. Amison et al. · British Journal of Pharmacology
Open access |
28 May 2020 |
192 |
| 25 |
Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALS
Claire E. Hall et al. · Cell Reports
Open access |
May 2017 |
189 |
| 26 |
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19
George R. Painter, Michael G. Natchus, Oren J. Cohen et al. · Current Opinion in Virology
ReviewOpen access |
18 Jun 2021 |
177 |
| 27 |
Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: A follow-up to an ECVAM workshop
David Kirkland, Peter Kasper, Lutz Müller et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
|
12 Apr 2008 |
177 |
| 28 |
Bioanalytical Approaches to Analyzing Peptides and Proteins by LC–MS/MS
Matthew Ewles, Lee Goodwin · Bioanalysis
|
Jun 2011 |
167 |
| 29 |
Parabens can enable hallmarks and characteristics of cancer in human breast epithelial cells: a review of the literature with reference to new exposure data and regulatory status
Philippa D. Darbre, Philip W. Harvey · Journal of Applied Toxicology
|
22 Jul 2014 |
167 |
| 30 |
Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity: Genotoxic effects of zinc oxide in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells
Eric K. Dufour, T. S. Kumaravel, Gerhard J. Nohynek et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
|
22 Jun 2006 |
162 |
| 31 |
Assessment of the genotoxic and carcinogenic risks of p-nitrophenol when it is present as an impurity in a drug product
Gary M. Eichenbaum, Mark Johnson, David Kirkland et al. · Regulatory Toxicology and Pharmacology
|
15 Jun 2009 |
157 |
| 32 |
Endocrine disrupters and human health: could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women?
Philip W. Harvey, Philippa D. Darbre · Journal of Applied Toxicology
|
May 2004 |
156 |
| 33 |
Voriconazole, a novel wide‐spectrum triazole: oral pharmacokinetics and safety
Lynn Purkins, Nolan Wood, Katie Greenhalgh et al. · British Journal of Clinical Pharmacology
Open access |
17 Nov 2003 |
149 |
| 34 |
Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit
Robert L. Clark, Tacey E. K. White, Sally A. Clode et al. · Birth Defects Research Part B Developmental and Reproductive Toxicology
|
Dec 2004 |
143 |
| 35 |
Mouse lymphoma thymidine kinase gene mutation assay: Follow‐up meeting of the international workshop on Genotoxicity testing—Aberdeen, Scotland, 2003—Assay acceptance criteria, positive controls, and data evaluation
Martha M. Moore et al. · Environmental and Molecular Mutagenesis
|
30 Jun 2005 |
143 |
| 36 |
Interpretation of the biological relevance of genotoxicity test results: the importance of thresholds
David Kirkland, Lutz Müller · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
|
2000 |
141 |
| 37 |
Safety assessment of astaxanthin-rich microalgae biomass: Acute and subchronic toxicity studies in rats
John S. Stewart, Åke Lignell, Annette Frost Pettersson et al. · Food and Chemical Toxicology
|
11 Jun 2008 |
139 |
| 38 |
Strategy for genotoxicity testing: Hazard identification and risk assessment in relation to in vitro testing
V. Thybaud, Marilyn J. Aardema, Julie M. Clements et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
|
28 Nov 2006 |
135 |
| 39 |
Comparison of different methods for an accurate assessment of cytotoxicity in the in vitro micronucleus test
Elisabeth Lorge, Makoto Hayashi, Silvio Albertini et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
|
15 Jun 2008 |
134 |
| 40 |
Significance of the detection of esters of p‐hydroxybenzoic acid (parabens) in human breast tumours
Philip W. Harvey, David J. Everett · Journal of Applied Toxicology
|
2004 |
132 |
| 41 |
Intravenous Safety and Pharmacokinetics of a Novel Dimerizer Drug, AP1903, in Healthy Volunteers
John D. Iuliucci, Stuart D. Oliver, Steven K. Morley et al. · The Journal of Clinical Pharmacology
|
Aug 2001 |
130 |
| 42 |
Nonproliferative and Proliferative Lesions ofthe Gastrointestinal Tract, Pancreas andSalivary Glands of the Rat and Mouse
Thomas Nolte, Patricia Brander-Weber, Charles A. Dangler et al. · Journal of Toxicologic Pathology
Open access |
2016 |
129 |
| 43 |
A randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12 weeks
Ana Santos Cravo, Jim A. Bush, Girish C. Sharma et al. · Regulatory Toxicology and Pharmacology
Open access |
18 Oct 2016 |
128 |
| 44 |
NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical Methods
Maria Lorna A. De Leoz et al. · Molecular & Cellular Proteomics
Open access162 authors |
7 Oct 2019 |
126 |
| 45 |
Predictive Models for Carcinogenicity and Mutagenicity: Frameworks, State-of-the-Art, and Perspectives
Emilio Benfenati, Romualdo Benigni, David M. DeMarini et al. · Journal of Environmental Science and Health Part C
|
May 2009 |
124 |
| 46 |
The inequity of informal payments for health care: The case of Hungary
Ágota Szende, Anthony J. Culyer · Health Policy
|
26 May 2005 |
123 |
| 47 |
A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer
Gerlinde Pilkington, Angela Boland, Tamara J. Brown et al. · Thorax
ReviewOpen access |
6 Feb 2015 |
118 |
| 48 |
Evaluation of the rodent micronucleus assay by a 28‐day treatment protocol: Summary of the 13th Collaborative Study by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Environmental Mutagen Society of Japan (JEMS)–Mammalian Mutagenicity Study Group (MMS)
Shuichi Hamada et al. · Environmental and Molecular Mutagenesis
|
2001 |
118 |
| 49 |
In vivo erythrocyte micronucleus assay
Makoto Hayashi, James T. MacGregor, David G. Gatehouse et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
|
7 Dec 2006 |
114 |
| 50 |
An assessment of the genotoxicity and human health risk of topical use of kojic acid [5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one]
Gerhard J. Nohynek, David Kirkland, Daniel R. Marzin et al. · Food and Chemical Toxicology
|
11 Oct 2003 |
113 |